Septrin 960mg 10x10 Tab

Septrin 960mg 10x10 Tab

"Septrin, also known as cotrimoxazole, is an antibiotic medication that combines two active ingredients: sulfamethoxazole and trimethoprim. The 960mg formulation typically contains 800 mg of sulfamethoxazole and 160 mg of trimethoprim. This combination is effective against a wide range of bacterial infections.

Key Features
- Composition: Each tablet contains 960 mg of cotrimoxazole (800 mg sulfamethoxazole and 160 mg trimethoprim).
- Packaging: Available in a pack of 10 tablets, suitable for short-term treatment regimens.

Indications
Septrin is indicated for the treatment of:
- Urinary Tract Infections (UTIs): Effective against various bacteria causing UTIs.
- Respiratory Infections: Used for conditions such as bronchitis and pneumonia, particularly in immunocompromised individuals.
- Gastrointestinal Infections: Effective for treating traveler's diarrhea and shigellosis.
- Pneumocystis Jirovecii Pneumonia (PCP): Commonly used as prophylaxis or treatment in patients with HIV/AIDS.

Dosage Instructions
- Adults: The usual dosage for treating infections is typically 1 tablet (960 mg) taken twice daily. The exact duration depends on the type and severity of the infection, often ranging from 5 to 14 days.
- Children: Dosage for children is based on weight and should be determined by a healthcare provider.

Side Effects
Common side effects may include:
- Nausea and vomiting
- Diarrhea
- Skin rashes or allergic reactions
- Loss of appetite

Serious side effects can include:
- Severe skin reactions (e.g., Stevens-Johnson syndrome)
- Blood disorders (e.g., leukopenia, thrombocytopenia)
- Liver toxicity

Patients should seek immediate medical attention if they experience severe reactions such as difficulty breathing, swelling, or any signs of severe skin rash.

Precautions
- Contraindications: Not recommended for individuals with known hypersensitivity to sulfonamides or trimethoprim.
- Use with caution in patients with kidney or liver impairment, or those with a history of blood disorders.
- Patients should be monitored for signs of adverse reactions, especially during prolonged therapy."
USh 200

(estimated)

USh 500